Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardian Pharmacy Services (GRDN) Notes Payables (2023 - 2024)

Guardian Pharmacy Services (GRDN) has disclosed Notes Payables for 2 consecutive years, with $5.4 million as the latest value for Q3 2024.

  • Quarterly Notes Payables changed N/A to $5.4 million in Q3 2024 from the year-ago period, while the trailing twelve-month figure was $5.4 million through Sep 2024, changed N/A year-over-year, with the annual reading at $4.0 million for FY2023, N/A changed from the prior year.
  • Notes Payables hit $5.4 million in Q3 2024 for Guardian Pharmacy Services, up from $4.0 million in the prior quarter.
  • In the past five years, Notes Payables ranged from a high of $5.4 million in Q3 2024 to a low of $4.0 million in Q4 2023.